drugset / Trial / NCT03445910

Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI

NCT03445910

Completed 100 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

Despite recent advances in clinical and laboratory techniques of Assisted Reproductive Technology (ART), the pregnancy rate remains around 30% per cycle. It has been estimated that 50% to 75% of lost pregnancies are due to failure of implantation. The process of implantation is a locally controlled paracrine/juxtacrine-mediated phenomenon. Successful implantation depends on the synchronized "cross-talk" between a functional blastocyst and a "receptive" endometrium. This process leads to apposition, attachment and invasion of embryos and subsequent normal placentation. So the objective of this study is investigate the impact of intrauterine injection of human chorionic gonadotropin (hCG) at the day of ovum pick-up on implantation and pregnancy rates in patients with recurrent implantation failure.

Timeline

Start
2018-02-20
Primary completion
2018-06-01
Completion
2018-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject human chorionic gonadotropin Protein / enzyme biologic 500 iu Other

Indications